Ophthalmology News

Ophthal

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Sawa M et al. - An intravitreal injection of bevacizumab seems to maintain visual acuity. However, CNV frequently recurred or new CNV developed during the long follow-up.

Related Articles

Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion
Graefe's Archive for Clinical and Experimental Ophthalmology, 11/11/09    Relevance Score: 69%

Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion
Eye, 10/06/09    Relevance Score: 69%

Visual outcomes and growth factor changes of two dosages of intravitreal bevacizumab for neovascular age-related macular degeneration
Retina, 11/11/09    Relevance Score: 68%

Bevacizumab Improves Macular Edema
Review of Ophthalmology, 10/02/09    Relevance Score: 67%

Functional changes following combined intravitreal bevacizumab and photodynamic therapy for polypoidal choroidal vasculopathy
Graefe's Archive for Clinical and Experimental Ophthalmology, 10/20/09    Relevance Score: 66%

Today in Retina...keeping you current

Pathophysiology and management of diabetic retinopathy
Expert Review of Ophthalmology, 12/07/09

Treatment of branch retinal vein occlusion
Expert Review of Ophthalmology, 12/07/09

Measurement of quality of life for people with diabetic retinopathy impairment
Expert Review of Ophthalmology, 12/07/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address